Presentation Title

Derivatization of 1,3-dimethylamylamine and Analysis by GC-MS

Presenter Information

James DeFrancescoFollow

Major

Forensic Science

Anticipated Graduation Year

2020 (2020-21 AY, fall 2020 grad)

Access Type

Open Access

Abstract

The subject compound, 1,3-dimethylamylamine (DMAA), is a “natural” stimulant found in nutritional supplements, weight loss, and athletic performance-enhancing products. This amphetamine-like compound is linked to cardiovascular problems such as shortness of breath, arrhythmias, chest tightness, heart attacks, and multiple deaths. DMAA was banned in 2010 by the International Association of Athletics and the International Olympic Committee which both abide by the policies set forth by the World Anti-Doping Agency. Our laboratory recently developed a method to determine the presence and amount of DMAA in commercial products by GC-MS in full scan and SIM modes. By careful selection of the derivatizing alkanoic anhydride, the sensitivity of the method can be significantly enhanced. Our group is in the process of applying this technique to the analysis of controlled substances such as Amphetamine, Methamphetamine, MDA, and MDMA.

Community Partners

Loyola University Chicago

Faculty Mentors & Instructors

James DeFrancesco

Comments

My student conducted the research for this poster last term (fall 2020) and graduated. I tried to enter her email address, but it is no longer valid (nizquierdo@luc.edu). She may have deactivated her account.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

This document is currently not available here.

Share

COinS
 

Derivatization of 1,3-dimethylamylamine and Analysis by GC-MS

The subject compound, 1,3-dimethylamylamine (DMAA), is a “natural” stimulant found in nutritional supplements, weight loss, and athletic performance-enhancing products. This amphetamine-like compound is linked to cardiovascular problems such as shortness of breath, arrhythmias, chest tightness, heart attacks, and multiple deaths. DMAA was banned in 2010 by the International Association of Athletics and the International Olympic Committee which both abide by the policies set forth by the World Anti-Doping Agency. Our laboratory recently developed a method to determine the presence and amount of DMAA in commercial products by GC-MS in full scan and SIM modes. By careful selection of the derivatizing alkanoic anhydride, the sensitivity of the method can be significantly enhanced. Our group is in the process of applying this technique to the analysis of controlled substances such as Amphetamine, Methamphetamine, MDA, and MDMA.